Similarly lower levels of staining for p-ERK1/2 were observed in the colon (Figure 7(Eg,Eh)), suggesting that the inactivation of the Klk6 gene may be associated with reduction of ERK1/2 pathway activation during CRC development. The gene discussed is MAPK3; the disease is colorectal carcinoma.